Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8795)
All Articles published online
|
Feb 21, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Villanacci V, Antonelli E, Geboes K, Casella G, Bassotti G. Histological healing in inflammatory bowel disease: A still unfulfilled promise. World J Gastroenterol 2013; 19(7): 968-978 [PMID: 23467585 DOI: 10.3748/wjg.v19.i7.968] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i7/968.htm |
| Number | Citing Articles |
| 1 |
Amirkaveh Mojtahed, Reena Khanna, William J. Sandborn, Geert R. DʼHaens, Brian G. Feagan, Lisa M. Shackelton, Kenneth A. Baker, Elena Dubcenco, Mark A. Valasek, Karel Geboes, Barrett G. Levesque. Assessment of Histologic Disease Activity in Crohnʼs Disease. Inflammatory Bowel Diseases 2014; 20(11): 2092 doi: 10.1097/MIB.0000000000000155
|
| 2 |
|
| 3 |
Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02157-5
|
| 4 |
V. Villanacci, G. Bassotti, C. Langner. Histological Remission in Inflammatory Bowel Disease: Where Are We, and Where Are We Going?. Journal of Crohn's and Colitis 2015; 9(5): 428 doi: 10.1093/ecco-jcc/jjv043
|
| 5 |
Alissa Walsh, Andrey Kormilitzin, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, Holm Uhlig, John Geddes, Guy Goodwin, Michele Peters, Gary Collins, Simon Travis. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis. Journal of Crohn's and Colitis 2019; 13(4): 424 doi: 10.1093/ecco-jcc/jjy184
|
| 6 |
Vincenzo Villanacci, Luca Reggiani-Bonetti, Flavio Caprioli, Luca Saragoni, Tiziana Salviato, Claudia Mescoli, Gabriella Canavese, Stefania Manenti, Elisabetta Spada, Luigi Baron, Giuseppe Leoncini, Moris Cadei, Serena Battista, Alessandro Armuzzi. Histopathology of inflammatory bowel disease — Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC). Digestive and Liver Disease 2020; 52(3): 262 doi: 10.1016/j.dld.2019.11.005
|
| 7 |
Murat Cayci, Erdal Birol Bostanci, Nesrin Turhan, Kerem Karaman, Tahsin Dalgic, Ilter Ozer, Metin Ercan, Murat Ulas, Musa Akoglu. The analysis of clinico-pathologic characteristics in patients who underwent surgery due to stricturing and non-perineal fistulizing forms of Crohn's disease: A retrospective cohort study. International Journal of Surgery 2015; 15: 49 doi: 10.1016/j.ijsu.2015.01.029
|
| 8 |
Giuseppe Frieri, Brigida Galletti, Mirko Di Ruscio, Rachele Tittoni, Annalisa Capannolo, Donatella Serva, Giovanni Latella, Laura Sollima, Pietro Leocata, Stefano Necozione, Rosamarie Frieri, Angelo Viscido. The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine. Therapeutic Advances in Gastroenterology 2017; 10(10): 749 doi: 10.1177/1756283X17722926
|
| 9 |
Mao Matsubayashi, Taku Kobayashi, Shinji Okabayashi, Masaru Nakano, Shintaro Sagami, Ryo Ozaki, Hiroki Kiyohara, Hiromu Morikubo, Kunio Asonuma, Yusuke Miyatani, Shin Maeda, Toshifumi Hibi. Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitis. Journal of Gastroenterology and Hepatology 2021; 36(4): 943 doi: 10.1111/jgh.15220
|
| 10 |
Robert V Bryant, Daniel C Burger, Joseph Delo, Alissa J Walsh, Sally Thomas, Axel von Herbay, Otto C Buchel, Lydia White, Oliver Brain, Satish Keshav, Bryan F Warren, Simon P L Travis. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 2016; 65(3): 408 doi: 10.1136/gutjnl-2015-309598
|
| 11 |
Hwajeong Lee, Maria Westerhoff, Bo Shen, Xiuli Liu. Clinical Aspects of Idiopathic Inflammatory Bowel Disease: A Review for Pathologists. Archives of Pathology & Laboratory Medicine 2016; 140(5): 413 doi: 10.5858/arpa.2015-0305-RA
|
| 12 |
Erica E. Alexeev, Alexander S. Dowdell, Morkos A. Henen, Jordi M. Lanis, J. Scott Lee, Ian M. Cartwright, Rachel E. M. Schaefer, Alfredo Ornelas, Joseph C. Onyiah, Beat Vögeli, Sean P. Colgan. Microbial‐derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage. The FASEB Journal 2021; 35(5) doi: 10.1096/fj.202100027R
|
| 13 |
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca, Giovanni Brandimarte. Managing ambulatory ulcerative colitis patients with infliximab: A long-term follow-up study in primary gastroenterology centers. European Journal of Internal Medicine 2014; 25(8): 757 doi: 10.1016/j.ejim.2014.07.007
|
| 14 |
Giuseppe LEONCINI, Luca REGGIANI-BONETTI, Gloria SIMONCELLI, Vincenzo VILLANACCI. Histology of IBD and related colitides in the elderly. Minerva Gastroenterology 2024; 70(1) doi: 10.23736/S2724-5985.21.02888-6
|
| 15 |
Bence Kővári, Ágnes Báthori, Mark S. Friedman, Gregory Y. Lauwers. Histologic Diagnosis of Inflammatory Bowel Diseases. Advances in Anatomic Pathology 2022; 29(1): 48 doi: 10.1097/PAP.0000000000000325
|
| 16 |
Jan MELEK, Markéta ŠTANCLOVÁ, Petr DĚDEK, Radek ŠTICHHAUER, Jaroslav KOUDELKA, Tomáš DOUDA, Ilja TACHECÍ, Ladislav DOUDA, Tomáš VAŇÁSEK, Jan BUREŠ. Mucosal healing is not associated with better outcome during 7 years of follow-up in pediatric patients with Crohn's disease. Minerva Pediatrics 2024; 76(3) doi: 10.23736/S2724-5276.21.06099-0
|
| 17 |
Emre Turer, William McAlpine, Kuan-wen Wang, Tianshi Lu, Xiaohong Li, Miao Tang, Xiaoming Zhan, Tao Wang, Xiaowei Zhan, Chun-Hui Bu, Anne R. Murray, Bruce Beutler. Creatine maintains intestinal homeostasis and protects against colitis. Proceedings of the National Academy of Sciences 2017; 114(7) doi: 10.1073/pnas.1621400114
|
| 18 |
R.V. Bryant, S. Winer, Travis SPL, R.H. Riddell. Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn's and Colitis 2014; 8(12): 1582 doi: 10.1016/j.crohns.2014.08.011
|
| 19 |
Savini L. Santha, Prabhu R. Shankar, Anqi Pan, Bess Schoen, Subra Kugathasan, Cary G. Sauer. Mucosal Healing in Clinical Practice. Inflammatory Bowel Diseases 2017; 23(8): 1447 doi: 10.1097/MIB.0000000000001176
|
| 20 |
Francesca Paola Giugliano, Caterina Strisciuglio, Massimo Martinelli, Marialuisa Andreozzi, Sabrina Cenni, Severo Campione, Maria D’Armiento, Annamaria Staiano, Erasmo Miele. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study. Digestive and Liver Disease 2018; 50(3): 240 doi: 10.1016/j.dld.2017.10.017
|
| 21 |
Joshua Royal, Nobuyuki Matoba. Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa. Toxins 2017; 9(12): 379 doi: 10.3390/toxins9120379
|
| 22 |
Jan Melek, Markéta Štanclová, Petr Dědek, Jan Malý, Milan Bayer, Oldřich Pozler, Jan Bureš. Infliximab plus azathioprine is more effective than azathioprine alone in achieving mucosal healing in pediatric patients with Crohn's disease. Journal of Digestive Diseases 2020; 21(12): 705 doi: 10.1111/1751-2980.12927
|
| 23 |
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca, Giovanni Brandimarte. Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres. European Journal of Internal Medicine 2014; 25(5): 485 doi: 10.1016/j.ejim.2014.02.010
|
| 24 |
Robert V Bryant, Oliver Brain, Simon P.L. Travis. Conventional drug therapy for inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015; 50(1): 90 doi: 10.3109/00365521.2014.968864
|
| 25 |
A. S. Tertychnyi, Kh. M. Akhrieva, I. V. Maev, O. V. Zayratyants, L. S. Selivanova. Diagnostic problems of histological remission in patients with inflammatory bowel disease. Arkhiv patologii 2017; 79(3): 3 doi: 10.17116/patol20177933-9
|
| 26 |
Sumit Sharma, Vivek R. Sinha. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa. Journal of Controlled Release 2018; 272: 97 doi: 10.1016/j.jconrel.2018.01.003
|
| 27 |
Brooke M. Bullard, Sierra J. McDonald, Thomas D. Cardaci, Brandon N. VanderVeen, Ahmed D. Mohammed, Jason L. Kubinak, Joseph F. Pierre, Ioulia Chatzistamou, Daping Fan, Lorne J. Hofseth, E. Angela Murphy. Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 326(5): G591 doi: 10.1152/ajpgi.00004.2024
|
| 28 |
Neeraj Narula, Achuthan Aruljothy, Abdul‐Aziz Alshahrani, Ma’ayan Fadida, Mona Al‐Saedi, John K. Marshall, David T. Rubin, Britt Christensen. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Alimentary Pharmacology & Therapeutics 2020; 52(11-12): 1676 doi: 10.1111/apt.16147
|
| 29 |
Anna Wiernicka, Sylwia Szymanska, Joanna Cielecka-Kuszyk, Maciej Dadalski, Jaroslaw Kierkus. Histological healing after infliximab induction therapy in children with ulcerative colitis. World Journal of Gastroenterology 2015; 21(37): 10654-10661 doi: 10.3748/wjg.v21.i37.10654
|
| 30 |
Sei Adachi, Hiroshi Arakawa, Seita Koyama, Keisuke Saito, Zensho Ito, Yoshihiro Matsumoto, Kazuki Takakura, Shintaro Tsukinaga, Shunichi Odahara, Toyokazu Yukawa, Mikio Kajihara, Kan Uchiyama, Shigeo Koido, Toshifumi Ohkusa, Hisao Tajiri. Correlation between endoscopic healing and histological healing of ulcerative colitis determined using the Mayo score. Progress of Digestive Endoscopy 2014; 85(1): 43 doi: 10.11641/pde.85.1_43
|
| 31 |
Giovanna A. Belo, Bárbara F. Cordeiro, Emiliano R. Oliveira, Marina P. Braga, Sara H. da Silva, Bruno G. Costa, Flaviano dos S. Martins, Gwénaël Jan, Yves Le Loir, Alfonso Gala-García, Enio Ferreira, Vasco Azevedo, Fillipe L. R. do Carmo. SlpB Protein Enhances the Probiotic Potential of L. lactis NCDO 2118 in Colitis Mice Model. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.755825
|
| 32 |
Javier Ampuero, María Rojas‐Feria, Manuel Castro‐Fernández, Marina Millán‐Lorenzo, Pedro Guerrero-Jiménez, Manuel Romero‐Gómez. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice. Journal of Gastroenterology and Hepatology 2016; 31(1): 112 doi: 10.1111/jgh.13039
|
| 33 |
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Diogo Branquinho, Luís Correia, Samuel Fernandes, Marília Cravo, Paulo Caldeira, Helena Tavares de Sousa, Marta Patita, Paula Lago, Jaime Ramos, Joana Afonso, Isabel Redondo, Patrícia Machado, George Philip, Joanne Lopes, Fátima Carneiro. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819869141
|
| 34 |
Marion Lirsac, Amélie Biron, Zoubir Djerada, Guillaume Cadiot, Elise Morcos-Sauvain, Hedia Brixi, Margaux Le Saint, Aude Marchal, Camille Boulagnon-Rombi. Histological Indices and Risk of Recurrence in Crohn’s Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission. Inflammatory Bowel Diseases 2022; 28(9): 1395 doi: 10.1093/ibd/izac074
|
| 35 |
V. Villanacci, M. Salemme, G. Bassotti, E. Antonelli. Letter: histological assessment of disease activity in ulcerative colitis – the problem of score evaluation and validation. Alimentary Pharmacology & Therapeutics 2016; 43(3): 438 doi: 10.1111/apt.13473
|
| 36 |
Haggai Bar-Yoseph, Alexandra Blatt, Shiran Gerassy, Sigal Pressman, Amjad Mousa, Edmond Sabo, Matti Waterman, Bella Ungar, Shomron Ben-Horin, Yehuda Chowers. Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients. Journal of Crohn's and Colitis 2022; 16(6): 884 doi: 10.1093/ecco-jcc/jjab208
|
| 37 |
A. Marchal Bressenot, R. H. Riddell, C. Boulagnon-Rombi, W. Reinisch, S. Danese, S. Schreiber, L. Peyrin-Biroulet. Review article: the histological assessment of disease activity in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2015; 42(8): 957 doi: 10.1111/apt.13375
|
| 38 |
Mark Löwenberg, Severine Vermeire, Nahid Mostafavi, Frank Hoentjen, Denis Franchimont, Peter Bossuyt, Pieter Hindryckx, Theo Rispens, Annick de Vries, C. Janneke van der Woude, Sophie Berends, Carmen A. Ambarus, Ron Mathot, Esme Clasquin, Filip Baert, Geert D’Haens. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease. Gastroenterology 2019; 157(4): 997 doi: 10.1053/j.gastro.2019.05.067
|
| 39 |
Luca Scarallo, Patrizia Alvisi, Giulia Bolasco, Michele Di Toma, Marcello Lanari, Alice Cangiari, Monica Paci, Sara Naldini, Sara Renzo, Jacopo Barp, Salvatore De Masi, Paolo Lionetti. Mucosal and Histologic Healing in Children With Inflammatory Bowel Disease Treated With Antitumor Necrosis Factor-Alpha. Journal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 728 doi: 10.1097/MPG.0000000000003043
|
| 40 |
A. Caputo, P. Parente, M. Cadei, M. Fassan, A. Rispo, G. Leoncini, G. Bassotti, R. Del Sordo, C. Metelli, M. Daperno, A. Armuzzi, V. Villanacci. Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability. Techniques in Coloproctology 2022; 26(9): 713 doi: 10.1007/s10151-022-02628-7
|
| 41 |
G. Bassotti, E. Antonelli, V. Villanacci, R. Nascimbeni, M. P. Dore, G. M. Pes, G. Maconi. Abnormal gut motility in inflammatory bowel disease: an update. Techniques in Coloproctology 2020; 24(4): 275 doi: 10.1007/s10151-020-02168-y
|
| 42 |
Rish K. Pai, Geert D’Haens, Taku Kobayashi, Bruce E. Sands, Simon Travis, Vipul Jairath, Gert De Hertogh, Bomina Park, Kim McGinnis, Isabel Redondo, Nicole G. Lipitz, Theresa Hunter Gibble, Fernando Magro. Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials. Expert Review of Gastroenterology & Hepatology 2024; 18(1-3): 73 doi: 10.1080/17474124.2024.2326838
|
| 43 |
Pinelopi Nterma, Eleni Panopoulou, Eleni Papadaki-Petrou, Martha Assimakopoulou. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine. Pathology & Oncology Research 2020; 26(1): 567 doi: 10.1007/s12253-018-00575-z
|
| 44 |
Olga Maria Nardone, Rosanna Cannatelli, Davide Zardo, Subrata Ghosh, Iacucci Marietta. Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819863015
|
| 45 |
Marzia Lazzerini, Vincenzo Villanacci, Maria Chiara Pellegrin, Stefano Martelossi, Giuseppe Magazzù, Salvatore Pellegrino, Maria Cristina Lucanto, Arrigo Barabino, Angela Calvi, Serena Arrigo, Paolo Lionetti, Massimo Fontana, Giovanna Zuin, Giuseppe Maggiore, Matteo Bramuzzo, Massimo Maschio, Marianna Salemme, Stefania Manenti, Luisa Lorenzi, Giuliana Decorti, Marcella Montico, Alessandro Ventura. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide. Clinical Gastroenterology and Hepatology 2017; 15(9): 1382 doi: 10.1016/j.cgh.2017.02.029
|
| 46 |
Vincenzo Villanacci, Mattia Bugatti, Stefania Zini, Rachele Del Sordo, Gabrio Bassotti. Letter: The importance of histological assessment—a further stride in STRIDE. Alimentary Pharmacology & Therapeutics 2023; 58(11-12): 1244 doi: 10.1111/apt.17717
|
| 47 |
Weiming Lai, Changxiu Xian, Mingxia Chen, Ding Luo, Junxia Zheng, Suqing Zhao, Xiang-Guang Li. Single-cell and bulk transcriptomics reveals M2d macrophages as a potential therapeutic strategy for mucosal healing in ulcerative colitis. International Immunopharmacology 2023; 121: 110509 doi: 10.1016/j.intimp.2023.110509
|
| 48 |
Elisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti. Novel oral-targeted therapies for mucosal healing in ulcerative colitis. World Journal of Gastroenterology 2018; 24(47): 5322-5330 doi: 10.3748/wjg.v24.i47.5322
|
| 49 |
Jesse Kresak, Bo Shen, Xiuli Liu. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020; : 525 doi: 10.1016/B978-0-12-814811-2.00034-7
|
| 50 |
Min-Jin Kwak, Dong-Jin Ha, Yong-Soon Choi, Hanbae Lee, Kwang-Youn Whang. Protective and restorative effects of sophorolipid on intestinal dystrophy in dextran sulfate sodium-induced colitis mouse model. Food & Function 2022; 13(1): 161 doi: 10.1039/D1FO03109K
|
| 51 |
Karel Geboes, Maria Leo, Daniela Fanni, Gavino Faa. Colitis. 2014; : 93 doi: 10.1007/978-3-319-08028-4_6
|
| 52 |
Yaron Niv, Eyal Gal, Violeta Gabovitz, Marcela Hershkovitz, Lev Lichtenstein, Irit Avni. Capsule Endoscopy Crohn’s Disease Activity Index (CECDAIic or Niv Score) for the Small Bowel and Colon. Journal of Clinical Gastroenterology 2018; 52(1): 45 doi: 10.1097/MCG.0000000000000720
|
| 53 |
Peter Bossuyt, Raf Bisschops, Séverine Vermeire, Gert De Hertogh. Variability in the Distribution of Histological Disease Activity in the Colon of Patients with Ulcerative Colitis. Journal of Crohn's and Colitis 2021; 15(4): 603 doi: 10.1093/ecco-jcc/jjaa206
|
| 54 |
Ruoxi Zhang, Chunhua Yu, Herbert J. Zeh, Haichao Wang, Guido Kroemer, Daniel J. Klionsky, Timothy R. Billiar, Rui Kang, Daolin Tang. Nuclear localization of STING1 competes with canonical signaling to activate AHR for commensal and intestinal homeostasis. Immunity 2023; 56(12): 2736 doi: 10.1016/j.immuni.2023.11.001
|
| 55 |
Misagh Alipour, Deenaz Zaidi, Rosica Valcheva, Juan Jovel, Inés Martínez, Consolato Sergi, Jens Walter, Andrew L. Mason, Gane Ka-Shu Wong, Levinus A. Dieleman, Matthew W. Carroll, Hien Q. Huynh, Eytan Wine. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis. Journal of Crohn's and Colitis 2016; 10(4): 462 doi: 10.1093/ecco-jcc/jjv223
|
| 56 |
Parambir S. Dulai, Barrett G. Levesque, Brian G. Feagan, Geert D’Haens, William J. Sandborn. Assessment of mucosal healing in inflammatory bowel disease: review. Gastrointestinal Endoscopy 2015; 82(2): 246 doi: 10.1016/j.gie.2015.03.1974
|
| 57 |
Alexander Rodriguez-Palacios, Fabio Cominelli. Crohn’s Disease–Like Ileitis and the Inhibitory Effect of Sucralose on Streptococci. Inflammatory Bowel Diseases 2019; 25(4): e34 doi: 10.1093/ibd/izy251
|
| 58 |
Elisabetta Antonelli, Gabriele Torti, Gabrio Bassotti. Inhibitors of the Janus Kinases. Journal of Clinical Gastroenterology 2019; 53(9): 635 doi: 10.1097/MCG.0000000000001250
|
| 59 |
Silvia Mazzuoli, Francesco W. Guglielmi, Elisabetta Antonelli, Marianna Salemme, Gabrio Bassotti, Vincenzo Villanacci. Definition and evaluation of mucosal healing in clinical practice. Digestive and Liver Disease 2013; 45(12): 969 doi: 10.1016/j.dld.2013.06.010
|
| 60 |
Luca Scarallo, Lorenzo Fioretti, Monica Paci, Sara Naldini, Sara Renzo, Jacopo Barp, Anna Gissi, Monica Di Paola, Vincenzo Villanacci, Paolo Lionetti. Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitis. Digestive and Liver Disease 2024; 56(1): 43 doi: 10.1016/j.dld.2023.06.020
|
| 61 |
Christopher G. Chapman, Vani J.A. Konda. Confocal laser endomicroscopy in inflammatory bowel disease: achieving new depths in mucosal healing. Gastrointestinal Endoscopy 2016; 83(4): 792 doi: 10.1016/j.gie.2015.11.002
|
| 62 |
Vincenzo Villanacci, Elisabetta Antonelli, Francesco Lanzarotto, Anna Bozzola, Moris Cadei, Gabrio Bassotti. Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07338-x
|
| 63 |
José R. Cruz-Muñoz, Tonatiuh Barrios-García, Eduardo E. Valdez-Morales, María F. Durán-Vazquez, Karen B. Méndez-Rodríguez, Alma Barajas-Espinosa, Fernando Ochoa-Cortes, María C. Martínez-Saldaña, Yenny A. Gómez-Aguirre, Raquel Guerrero Alba. Ethanolic extract from Lepidium virginicum L. ameliorates DNBS-induced colitis in rats. Journal of Ethnopharmacology 2022; 289: 115056 doi: 10.1016/j.jep.2022.115056
|
| 64 |
Rodrigo Papa Gobbi, Nicolás De Francesco, Constanza Bondar, Cecilia Muglia, Fernando Chirdo, Martín Rumbo, Andrés Rocca, Marta A. Toscano, Alicia Sambuelli, Gabriel A. Rabinovich, Guillermo H. Docena. A galectin‐specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders. BioFactors 2016; 42(1): 93 doi: 10.1002/biof.1252
|
| 65 |
Karel Geboes, Olivier Dewit, Tom G. Moreels, Gavino Faa, Anne Jouret-Mourin. Colitis. 2018; : 107 doi: 10.1007/978-3-319-89503-1_8
|
| 66 |
Joshua M. Royal, Young Jun Oh, Michael J. Grey, Wayne I. Lencer, Nemencio Ronquillo, Susan Galandiuk, Nobuyuki Matoba. A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response. The FASEB Journal 2019; 33(12): 13527 doi: 10.1096/fj.201901255R
|
| 67 |
Cristiana Popp, Radu Bogdan Mateescu. New Concepts in Inflammatory Bowel Disease. 2018; doi: 10.5772/intechopen.72893
|
| 68 |
BO Ajayi, IA Adedara, EO Farombi. Protective mechanisms of 6-gingerol in dextran sulfate sodium-induced chronic ulcerative colitis in mice. Human & Experimental Toxicology 2018; 37(10): 1054 doi: 10.1177/0960327117751235
|
| 69 |
Elham Aghamohamadi, Nastaran Asri †, Aylin Odak, Mohammad Rostami-Nejad, Vahid Chaleshi, Yasaman Hajinabi, Maryam Eslami, Saeed Mohammadian Haftcheshmeh, Fahimeh Sadat Gholam-Mostafaei, Hamid Asadzadeh-Aghdaei, Andrea Masotti, Mohammad Reza Zali. Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases. Molecular Biology Reports 2022; 49(7): 6085 doi: 10.1007/s11033-022-07397-y
|
| 70 |
Kelsey G. DeFrates, Elaine Tong, Jing Cheng, Ellen Heber‐Katz, Phillip B. Messersmith. A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis. Advanced Science 2024; 11(13) doi: 10.1002/advs.202304716
|
| 71 |
Camille Boulagnon-Rombi, Aude Marchal, Marion Lirsac, Magali Svrcek. Maladies inflammatoires chroniques intestinales : scores et optimisation des comptes rendus anatomopathologiques. Annales de Pathologie 2023; 43(3): 170 doi: 10.1016/j.annpat.2023.03.007
|
| 72 |
Antonio Tursi, Walter Elisei, Marcello Picchio, Giacomo Forti, Antonio Penna, Cosimo Damiano Inchingolo, Rosanna Nenna, Giovanni Brandimarte. Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab. Clinics and Research in Hepatology and Gastroenterology 2015; 39(1): 107 doi: 10.1016/j.clinre.2014.07.012
|
| 73 |
Tessa E H Römkens, Pim Kranenburg, Arjan van Tilburg, Carolien Bronkhorst, Iris D Nagtegaal, Joost P H Drenth, Frank Hoentjen. Assessment of Histological Remission in Ulcerative Colitis: Discrepancies Between Daily Practice and Expert Opinion. Journal of Crohn's and Colitis 2018; 12(4): 425 doi: 10.1093/ecco-jcc/jjx165
|
| 74 |
Dwight A. Winter, Maria E. Joosse, Saskia N. de Wildt, Jan Taminiau, Lissy de Ridder, Johanna C. Escher. Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 70(6): 763 doi: 10.1097/MPG.0000000000002631
|
| 75 |
Laurent Peyrin-Biroulet, Edward V. Loftus, Jean-Frédéric Colombel, Silvio Danese, Raquel Rogers, Jeffrey D. Bornstein, Jingjing Chen, Stefan Schreiber, Bruce E. Sands, Richard A. Lirio. Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY). Gastroenterology 2021; 161(4): 1156 doi: 10.1053/j.gastro.2021.06.015
|
| 76 |
Rodrigo Papa-Gobbi, Cecilia I. Muglia, Andrés Rocca, Renata Curciarello, Alicia M. Sambuelli, Martín Yantorno, Gustavo Correa, Luciano G. Morosi, Antonio Di Sabatino, Paolo Biancheri, Thomas T. MacDonald, Marta A. Toscano, Karina V. Mariño, Gabriel A. Rabinovich, Guillermo H. Docena. Spatiotemporal regulation of galectin-1-induced T-cell death in lamina propria from Crohn’s disease and ulcerative colitis patients. Apoptosis 2021; 26(5-6): 323 doi: 10.1007/s10495-021-01675-z
|
| 77 |
You Yeon Choi, Ki Moon Seong, Hyun Jung Lee, Seung Sook Lee, Areumnuri Kim. RETRACTED ARTICLE: Expansion of monocytic myeloid-derived suppressor cells ameliorated intestinal inflammatory response by radiation through SOCS3 expression. Cell Death & Disease 2021; 12(9) doi: 10.1038/s41419-021-04103-x
|
| 78 |
Peter Bossuyt, Séverine Vermeire. Treat to Target in Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2016; 14(1): 61 doi: 10.1007/s11938-016-0077-z
|
| 79 |
Stephanie N. Spohn, Francesca Bianco, Rachel B. Scott, Catherine M. Keenan, Alisha A. Linton, Conor H. O'Neill, Elena Bonora, Michael Dicay, Brigitte Lavoie, Rebecca L. Wilcox, Wallace K. MacNaughton, Roberto De Giorgio, Keith A. Sharkey, Gary M. Mawe. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon. Gastroenterology 2016; 151(5): 933 doi: 10.1053/j.gastro.2016.07.032
|